5Fried MW, Shiffman ML, Reddy KR,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J]. N Engl J Med,2002,347 (13) :975.
6Lindsay KL, Trepo C, Heintges T, et al. A randomized, doubleblind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C [J]. Hepatology,2001,34(2) :395.
7Manns MP,Mchutchison JC, Gordon SC,et al. Peginterferon alfa2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomized trial[J]Lancet,2001,358(9286) :958.
8McHutchison JG,Manns M, Patel K,et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C [J]. Gastroenterology, 2002,123(4) :1061.
9Poynard T, McHutchison J, Manns M, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C [J]. Gastroenterology,2002,122 (5): 1303.
10Fried MW. Side effects of therapy of hepatitis C and their management [J]. Hepatology,2002,36 (5 suppl: 11): S237.
